Hedge Funds Are Selling Xeris Pharmaceuticals, Inc. (XERS)
We at Insider Monkey have gone over 873 13F filings that hedge funds and prominent investors are required to file by the SEC.
Xeris Pharmaceuticals Inc (XERS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 18,000,000 | $21,095 | 0.47% | ||
| 2. | 9,975,000 | $11,690 | 0.55% | ||
| 3. | 7,950,000 | $9,374 | 0.5% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.06 | 10,000 | Officer, Director | 411,134 | 2020-12-09 | Filing | |
| $3.55 | 22,000 | Officer | 117,493 | 2020-05-13 | Filing | |
| $3.20 | 7,886 | Officer | 95,493 | 2020-05-08 | Filing | |
| $3.00 | 33,000 | Officer, Director | 401,134 | 2020-05-08 | Filing | |
| $1.97 | 4,000 | Officer | 57,083 | 2020-03-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.07 | 10,000 | Officer | 496,824 | 2021-04-12 | Filing | |
| $6.01 | 10,000 | Officer | 406,824 | 2021-01-13 | Filing | |
| $5.72 | 10,000 | Officer | 416,824 | 2021-01-11 | Filing | |
| $5.50 | 10,000 | Officer | 421,824 | 2020-01-13 | Filing | |
| $7.97 | 10,000 | Officer | 449,324 | 2019-10-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 10,500,000 | $12,123 | 0.01% | |
| 2. | 250,000 | $289 | 0.06% | |
| 3. | 70,024 | $179 | 0% | |
| 4. | 803 | $2 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is XERS A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) is a good investment right now.
Hedge Funds Are Crazy About Xeris Pharmaceuticals, Inc. (XERS)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Hedge Funds Have Never Been This Bullish On Xeris Pharmaceuticals, Inc. (XERS)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Selling Xeris Pharmaceuticals, Inc. (XERS)
A whopping number of 13F filings filed with U.S.
Is Xeris Pharmaceuticals, Inc. (XERS) A Good Stock To Buy?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Hedge Fund and Insider Trading News: Ray Dalio, Nelson Peltz, Weight Watchers International, Inc. (WTW), Xeris Pharmaceuticals Inc (XERS), Carolina Financial Corporation (CARO), and More
Hedge fund legend Ray Dalio, who runs Bridgewater Associates, is widely considered to be one of the most successful hedge fund managers in the world.
Hedge Fund and Insider Trading News: Carl Icahn, SkyBridge Capital, Xeris Pharmaceuticals Inc (XERS), Legacy Reserves LP Unit (LGCY), Pershing Gold Corp (PGLC), and More
(Reuters) - Activist investor Carl Icahn boosted his stake in Energen Corp (EGN.N), a filing showed on Tuesday, as he eyes a potential takeover of the oil and gas producer.
Billionaire Hedge Funds
